Correlation Between Alzamend Neuro and Cyclo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alzamend Neuro and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alzamend Neuro and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alzamend Neuro and Cyclo Therapeutics, you can compare the effects of market volatilities on Alzamend Neuro and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alzamend Neuro with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alzamend Neuro and Cyclo Therapeutics.

Diversification Opportunities for Alzamend Neuro and Cyclo Therapeutics

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Alzamend and Cyclo is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Alzamend Neuro and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Alzamend Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alzamend Neuro are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Alzamend Neuro i.e., Alzamend Neuro and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Alzamend Neuro and Cyclo Therapeutics

Given the investment horizon of 90 days Alzamend Neuro is expected to under-perform the Cyclo Therapeutics. In addition to that, Alzamend Neuro is 2.76 times more volatile than Cyclo Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Cyclo Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  159.00  in Cyclo Therapeutics on August 25, 2024 and sell it today you would lose (86.00) from holding Cyclo Therapeutics or give up 54.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alzamend Neuro  vs.  Cyclo Therapeutics

 Performance 
       Timeline  
Alzamend Neuro 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alzamend Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Cyclo Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Alzamend Neuro and Cyclo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alzamend Neuro and Cyclo Therapeutics

The main advantage of trading using opposite Alzamend Neuro and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alzamend Neuro position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.
The idea behind Alzamend Neuro and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk